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Dear Editor,
With great interest we read the article by Schröder et al. to
be published in a forthcoming issue of the Journal of
Gastrointestinal Surgery in which they investigated the
potential value of resecting the azygos vein in transthoracic
esophagectomy for esophageal cancer.1
During (robot-assisted) thoracoscopic esophagectomy,
the trunk of the azygos vein is often preserved as the
scopic ligation of the numerous intercostal veins is
technically difficult and time-consuming.2–6 One may
postulate that this may negatively affect the extent of
lymph node harvesting or the circumferential radical (R0)
resection rate.
Schröder et al. have, therefore, performed a prospec-
tive evaluation on the amount of lymph nodes surround-
ing the azygos vein in 92 patients with esophageal
cancer having undergone open transthoracic esopha-
gectomy with two-field lymphadenectomy.1 Lymph nodes
near the azygos vein were identified in 65% of patients and
metastases in these lymph nodes were found in 8%. They,
therefore, conclude that the dissection of the azygos vein
should not be abandoned, irrespective of the surgical
approach.
A comment should be made on the design of the
study. As clearly shown in Figure 2 of their article, they
dissected the azygos vein with the surrounding tissues
sharply from the esophagus, which is not representative
for (robot-assisted) thoracoscopic esophagectomy. In
(robot-assisted) thoracoscopic esophagectomy, subse-
quent to the ligation of the azygos arch, the mediastinal
dissection of the esophagus and surrounding tissues is
performed sharply along the azygos trunk. In this way,
the fatty tissue in between the esophagus and the azygos
vein (including the lymph nodes of stations 108 and 110)
as well as the thoracic duct are included in the
esophageal resected specimen and are not left in situ
when the trunk of the azygos vein is preserved.2 The
number of lymph nodes that will be left in situ with
(robot-assisted) thoracoscopic esophagectomy will, there-
fore, be much less than stated in this article. Indeed, in our
recently published cadaveric study in which we investi-
gated an identical research question, a mean amount of
only 0.67 lymph nodes were identified around the azygos
vein using the thoracoscopic dissection method.7 Using
this approach, in 60% of cadavers, no lymph nodes near
the azygos vein were detected at all. With regard to the
possible effect of azygos vein preservation on the radical
resection rate, we can refer to our first report on 21
esophageal cancer patients having undergone robot-assis-
ted thoracoscopic esophagectomy. The R0 resection rate
of 76% in that series is similar to that of open trans-
thoracic esophagectomy.2,8 In our opinion, it is, therefore,
justified to preserve the azygos trunk during (minimally
invasive) transthoracic esophagectomy.
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